
News|Articles|August 21, 2015
Suresh Ramalingam on Toxicities Associated With Immunotherapy in Different Disease Types
Author(s)Suresh S. Ramalingam
Key Takeaways
- Immunotherapy offers significant advantages over traditional cancer treatments but presents unique toxicity profiles requiring distinct management strategies.
- Immune-related toxicities can affect various organ systems, necessitating vigilant monitoring and intervention by oncologists.
Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Advertisement
Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
3
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
4
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
5




